ISIN | IE00BWBXM617 |
---|---|
Valor Number | 28805622 |
Bloomberg Global ID | |
Fund Name | SPDR S&P U.S. Health Care Select Sector UCITS ETF USD |
Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
Fund Provider | State Street Investment Management |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of large sized U. S. health care companies in the S&P 500 Index. |
Peculiarities |
Current Price * | 40.45 USD | 18.07.2025 |
---|---|---|
Previous Price * | 40.69 USD | 17.07.2025 |
52 Week High * | 47.56 USD | 02.09.2024 |
52 Week Low * | 39.37 USD | 14.05.2025 |
NAV * | 40.45 USD | 18.07.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 328,834,993 | |
Unit/Share Assets *** | 328,834,993 | |
Trading Information SIX |
YTD Performance | -3.48% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
---|---|---|
YTD Performance (in CHF) | -14.67% |
31.12.2024 - 18.07.2025
31.12.2024 18.07.2025 |
1 month | -0.59% |
18.06.2025 - 18.07.2025
18.06.2025 18.07.2025 |
3 months | -1.95% |
22.04.2025 - 18.07.2025
22.04.2025 18.07.2025 |
6 months | -5.30% |
20.01.2025 - 18.07.2025
20.01.2025 18.07.2025 |
1 year | -9.13% |
18.07.2024 - 18.07.2025
18.07.2024 18.07.2025 |
2 years | +2.56% |
18.07.2023 - 18.07.2025
18.07.2023 18.07.2025 |
3 years | +7.66% |
18.07.2022 - 18.07.2025
18.07.2022 18.07.2025 |
5 years | +32.80% |
20.07.2020 - 18.07.2025
20.07.2020 18.07.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 12.51% | |
---|---|---|
Johnson & Johnson | 7.50% | |
AbbVie Inc | 6.69% | |
UnitedHealth Group Inc | 5.77% | |
Abbott Laboratories | 4.83% | |
Merck & Co Inc | 4.05% | |
Intuitive Surgical Inc | 3.97% | |
Boston Scientific Corp | 3.24% | |
Thermo Fisher Scientific Inc | 3.12% | |
Amgen Inc | 3.06% | |
Last data update | 30.06.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.15% |
Ongoing Charges *** | 0.15% |
SRRI ***
|
|
SRRI date *** | 30.06.2025 |